Autologous serum eyedrops: Literature review and implications for transfusion medicine specialists

Transfusion

Volumn 48, Issue 6, 2008, Pages 1245-1255

  Yamada, Chisa ^a   King, Karen E ^a   Ness, Paul M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS SERUM EYEDROP; EYE DROPS;

CONJUNCTIVITIS; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA EROSION; CORNEA SENSIBILITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG STORAGE; ECZEMA; EYE DISCOMFORT; EYE PAIN; EYE SWELLING; HUMAN; IMMUNOGLOBULIN DEPOSITION; INTRAOCULAR PRESSURE; MICROBIAL CONTAMINATION; OCULAR PRURITUS; REVIEW; SIDE EFFECT; VASCULITIS;

AUTOANTIGENS; BLOOD TRANSFUSION; CORNEA; EPITHELIUM; HUMANS; INFERTILITY; OPHTHALMIC SOLUTIONS; SERUM;

EID: 44849102076     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01665.x     Document Type: Review

References (46)

1. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984 27 : 459 61.
2. McDonnell PJ, Schanzlin DJ, Rao NA. Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 1988 106 : 1423 5.
3. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996 122 : 38 52.
4. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999 83 : 390 5.
5. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999 106 : 1984 9.
6. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004 88 : 1467 74.
7. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005 243 : 706 14.
8. Fujikawa LS, Foster CS, Harrist TJ, Lanigan JM, Colvin RB. Fibronectin in healing rabbit corneal wounds. Lab Invest 1981 45 : 120 9.
9. Berman M, Manseau E, Law M, Aiken D. Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface. Invest Ophthalmol Vis Sci 1983 24 : 1358 66.
10. Kitazawa T, Kinoshita S, Fujita K, Araki K, Watanabe H, Ohashi Y, Manabe R. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. Invest Ophthalmol Vis Sci 1990 31 : 1773 8.
11. Pancholi S, Tullo A, Khaliq A, Foreman D, Boulton M. The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. Graefes Arch Clin Exp Ophthalmol 1998 236 : 1 8.
12. Wilson SE, Liang Q, Kim WJ. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci 1999 40 : 2185 90.
13. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000 19 : 113 29.
14. Nishida T, Nakamura M, Mishima H, Otori T. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 1991 53 : 753 8.
15. Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 1996 169 : 159 66.
16. Nakamura M, Nishida T, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Exp Eye Res 1997 65 : 321 9.
17. Smolin G, Okumoto M, Friedlaender M. Tretinoin and corneal epithelial wound healing. Arch Ophthalmol 1979 97 : 545 6.
18. Bilgihan K, Adiguzel U, Sezer C, Akyol G, Hasanreisoglu B. Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy. Ophthalmologica 2001 215 : 192 6.
19. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998 338 : 1174 80.
20. Fukuda M, Fullard RJ, Willcox MD, Baleriola-Lucas C, Bestawros F, Sweeney D, Holden BA. Fibronectin in the tear film. Invest Ophthalmol Vis Sci 1996 37 : 459 67.
21. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, Taylor HR. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001 20 : 802 6.
22. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001 85 : 1188 97.
23. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004 88 : 647 52.
24. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005 139 : 242 6.
25. Young AL, Cheng AC, Ng HK, Cheng LL, Leung GY, Lam DS. The use of autologous serum tears in persistent corneal epithelial defects. Eye 2004 18 : 609 14.
26. Schrader S, Wedel T, Moll R, Geerling G. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefes Arch Clin Exp Ophthalmol 2006 244 : 1345 9.
27. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000 25 : 1101 3.
28. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, Kuwana M, Tsubota K, Ikeda Y, Oguchi Y. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003 31 : 579 83.
29. Noda-Tsuruya T, Asano-Kato N, Toda I, Tsubota K. Autologous serum eye drops for dry eye after LASIK. J Refract Surg 2006 22 : 61 6.
30. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004 111 : 1115 20.
31. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol 2006 142 : 207 11.
32. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001 20 : 807 10.
33. del Castillo JM, de la Casa JM, Sardina RC, Fernandez RM, Feijoo JG, Gomez AC, Rodero MM, Sanchez JG. Treatment of recurrent corneal erosions using autologous serum. Cornea 2002 21 : 781 3.
34. Blajchman MA. Landmark studies that have changed the practice of transfusion medicine. Transfusion 2005 45 : 1523 30.
35. Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004 88 : 464 5.
36. Sauer R, Bluthner K, Seitz B Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects Ophthalmologe 2004 101 : 705 9.
37. Prabhasawat P, Chotikavanich S, Leelaporn A. Sterility of non-preservative eye drops. J Med Assoc Thai 2005 88 Suppl 9 : S6 10.
38. Berry M, Gurung A, Easty DL. Toxicity of antibiotics and antifungals on cultured human corneal cells: effect of mixing, exposure and concentration. Eye 1995 9 (Pt 1 110 5.
39. Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 2002 53 : 263 80.
40. Lazarus HM, Imperia PS, Botti RE, Mack RJ, Lass JH. An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents. Lens Eye Toxic Res 1989 6 : 59 85.
41. Stern GA, Schemmer GB, Farber RD, Gorovoy MS. Effect of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol 1983 101 : 644 7.
42. Pollock GA, McKelvie PA, McCarty DJ, White JF, Mallari PL, Taylor HR. In vivo effects of fluoroquinolones on rabbit corneas. Clin Experiment Ophthalmol 2003 31 : 517 21.
43. Hartwig D, Harloff S, Liu L, Schlenke P, Wedel T, Geerling G. Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 2004 44 : 1724 31.
44. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Kasper K, Geerling G. Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 2006 47 : 2438 44.
45. Koffler BH. Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel. Ocul Surf 2006 4 : 188 95.
46. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000 107 : 1347 51 discussion 51-2.